Team

Dr. Grace Xiaolu Yang

COO, VP of Research & Co-founder

Biography

“We hope Tality will become a safe and effective option of cancer care that helps patients manage their disease.”

Dr. Yang is a founder of Filtricine. She leads business and scientific operations at Filtricine. She is an inventor on the two patent applications filed by Filtricine.

Dr. Yang holds a PhD from Stanford University.

Our Team

Dr. John Chant
CEO
Dr. Xiyan Li
CSO & Co-founder
Dr. Jimmy Xin Wang
CTO & Co-founder
Mike Partsuf
Senior Food Scientist
Emily Sinovic
Public Relations Consultant
Todd Lorenz
Clinical Development Consultant

Our Advisors

Dr. Mike P Snyder
Chair of Genetics
Stanford University School of Medicine
Peter B Hutt
Former FDA Chief Counsel
Senior Counsel at Covington & Burling LLP
Brad Barnes
Director
Culinary Institute of America
Dr. Dariush Mozaffarian
Dean at the School of Nutrition Science
Tufts University
Dr. Yung-Chi Cheng
Henry Bronson Professor of Pharmacology
Yale University School of Medicine
Dr. Danhua Xiao
Nutrition & Metabolic Physician Specialist
Atlantic Health Metabolic Center
Dr. Joseph V Rodricks
Founding Principal
Ramboll (formerly ENVIRON)
Alister Thomson
Director
Bristol Myers Squibb (Former)
Jeff Depew
Board Director & Committee Chair
Sand Hill Angels
Dr. Wei Jiang
Senior Director
Medical Affairs at MorphoSys

Our Board of Directors

Dr. John Chant
CEO
Dr. Xiyan Li
CSO & Co-founder
Dr. Rami El Assal
Founding Partner at Boutique Venture Partners
Drew Lanza
Founding Partner at Berkeley Catalyst Fund
We are a clinical-stage biotechnology company based in the San Francisco Bay Area dedicated to developing novel food products for disease control.
© 2022 Filtricine, Inc. All Rights Reserved | by Wuilt